A RANDOMIZED CONTROL STUDY OF GEMFIBROZIL AND PANTETHINE ON ANTI-LIPID-PEROZIDATON IN DIABETES MELLITUS / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12)1986.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-674618
Responsible library:
WPRO
ABSTRACT
Randomized control study of gemfibrozil and pantethine was made in 39 NIDDM patients to compare their effect on anti-lipid-peroxidation.The patients were divided into two groups at random. One group took gcmfibrozil 900 mg/d for 4 weeks, the ether group took pantethine 540 mg/d for 4 weeks. The results showed that there were no significant change in faslirg plasma glucose and HbA1 in both groups before and after treatment. The effects on lipicls and lipcproteins in gemfi-barozil and pantethine groups were as follows TC decreased by 18.15% and 8.75% (P
Full text:
Available
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
1986
Document type:
Article
